Tadao Akizawa
#162,382
Most Influential Person Now
Researcher
Tadao Akizawa's AcademicInfluence.com Rankings
Tadao Akizawacomputer-science Degrees
Computer Science
#9444
World Rank
#9918
Historical Rank
Machine Learning
#4132
World Rank
#4181
Historical Rank
Artificial Intelligence
#4474
World Rank
#4535
Historical Rank
Database
#6410
World Rank
#6643
Historical Rank
Download Badge
Computer Science
Tadao Akizawa's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Tadao Akizawa Influential?
(Suggest an Edit or Addition)Tadao Akizawa's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2008) (969)
- Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. (2013) (796)
- Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. (2005) (744)
- Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study (2008) (530)
- Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2006) (471)
- Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2004) (393)
- Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. (2006) (384)
- Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. (2003) (352)
- Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. (2003) (330)
- Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2007) (283)
- Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder (2013) (276)
- Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices (2016) (269)
- 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease (2010) (228)
- Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2011) (209)
- Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. (2007) (200)
- 2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis (2006) (174)
- The associations of social support and other psychosocial factors with mortality and quality of life in the dialysis outcomes and practice patterns study. (2011) (169)
- HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. (2005) (158)
- World-wide, mortality is a high risk soon after initiation of hemodialysis (2013) (156)
- Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. (2009) (136)
- Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. (2004) (133)
- Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. (2007) (133)
- Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. (2012) (124)
- Chronic Kidney Disease Japan Cohort (CKD-JAC) Study: Design and Methods (2008) (115)
- Factors associated with health-related quality of life among hemodialysis patients in the DOPPS (2007) (112)
- Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2010) (109)
- Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. (2004) (109)
- Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2007) (108)
- Association of mineral metabolism factors with all‐cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study (2007) (108)
- Pruritus in hemodialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS) (2014) (107)
- Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. (2004) (102)
- IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. (2010) (100)
- Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan. (2020) (98)
- Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function (2010) (97)
- Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. (2009) (93)
- Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding. (1993) (86)
- Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis (2012) (83)
- Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients. (2012) (81)
- Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects (2016) (81)
- Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. (2006) (80)
- Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) (2013) (79)
- Cardiovascular events and death in Japanese patients with chronic kidney disease. (2017) (78)
- Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study (2007) (75)
- Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008 (2009) (71)
- Effects of Molidustat in the Treatment of Anemia in CKD. (2018) (71)
- Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study (2019) (70)
- Factors associated with health-related quality of life among hemodialysis patients in the DOPPS (2007) (68)
- Japanese haemodialysis anaemia management practices and outcomes (1999–2006): results from the DOPPS (2008) (67)
- Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding. (2014) (67)
- 2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients * (2004) (67)
- Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. (2003) (65)
- Vascular Access Care and Treatment Practices Associated with Outcomes of Arteriovenous Fistula: International Comparisons from the Dialysis Outcomes and Practice Patterns Study (2013) (63)
- Elastin Degradation Accelerates Phosphate-Induced Mineralization of Vascular Smooth Muscle Cells (2009) (63)
- Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study. (1996) (62)
- Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial (2019) (61)
- Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study) (2020) (60)
- A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial (2019) (59)
- Vitamin D and vascular calcification in chronic kidney disease. (2009) (58)
- Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study (2016) (58)
- Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease. (2011) (58)
- Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells. (2007) (57)
- Involvement of Alpha-Klotho and Fibroblast Growth Factor Receptor in the Development of Secondary Hyperparathyroidism (2010) (57)
- Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia. (2003) (57)
- Clinical correlates of ambulatory BP monitoring among patients with CKD. (2013) (57)
- Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial. (2020) (56)
- High Target Hemoglobin With Erythropoiesis‐Stimulating Agents Has Advantages in the Renal Function of Non‐Dialysis Chronic Kidney Disease Patients (2012) (56)
- Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. (2006) (56)
- Japanese Society for Dialysis Therapy Clinical Guideline for “Hemodialysis Initiation for Maintenance Hemodialysis” (2015) (55)
- Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. (2011) (55)
- Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non‐insulin‐dependent Otsuka Long‐Evans Tokushima Fatty rats (2011) (54)
- Clinical Effect of Recombinant Human Erythropoietin on Anemia Associated with Chronic Renal Failure. A Multiinstitutional Study in Japan (1988) (52)
- Health-Related Quality of Life of Predialysis Patients with Chronic Renal Failure (2006) (51)
- Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients. (2010) (51)
- Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α. (2012) (49)
- The organization and financing of end-stage renal disease treatment in Japan (2007) (49)
- Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism. (2018) (48)
- A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients (2017) (47)
- Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. (2015) (47)
- Incidence and clinical characteristics of hypoparathyroidism in dialysis patients. (1997) (46)
- Oral roxadustat three times weekly in ESA‐naïve and ESA‐converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies (2019) (46)
- Effect of β2-microglobulin adsorption column on dialysis-related amyloidosis (2003) (45)
- Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. (1991) (45)
- Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. (2011) (45)
- Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients. (2001) (45)
- Long-Term Cinacalcet HCl Treatment Improved Bone Metabolism in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism (2008) (45)
- Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats. (2004) (43)
- NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD (2017) (43)
- PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism (2016) (42)
- Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study. (2008) (42)
- A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis (2020) (41)
- Recent progress in management of secondary hyperparathyroidism of chronic renal failure. (1993) (41)
- Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study (2011) (41)
- COVID‐19 of dialysis patients in Japan: Current status and guidance on preventive measures (2020) (41)
- Protective Effect of an Oral Adsorbent on Renal Function in Chronic Renal Failure: Determinants of its Efficacy in Diabetic Nephropathy (2004) (40)
- Low health‐related quality of life is associated with all‐cause mortality in patients with diabetes on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study (2009) (40)
- Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients (2015) (39)
- Platelet-Derived Growth Factor Induces Tissue Factor Expression in Vascular Smooth Muscle Cells via Activation of Egr-1 (2004) (39)
- Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients--the Japanese strategy. Japanese Working Group on PEIT of Parathyroid, Tokyo, Japan. (1999) (39)
- A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro (2018) (39)
- Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study. (2002) (39)
- Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review (2018) (38)
- The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis. (2004) (38)
- Mineral Metabolism Management in Hemodialysis Patients with Secondary Hyperparathyroidism in Japan: Baseline Data from the MBD-5D (2011) (37)
- Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2005) (37)
- Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial (2019) (37)
- Efficiency and biocompatibility of a polyethylene glycol grafted cellulosic membrane during hemodialysis. (1989) (36)
- Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study (2011) (36)
- Impact of Fibroblast Growth Factor 23 on Lipids and Atherosclerosis in Hemodialysis Patients (2010) (36)
- Assessment of myeloperoxidase and oxidative alpha1-antitrypsin in patients on hemodialysis. (2009) (36)
- Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. (2013) (36)
- Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis. (2009) (34)
- Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies (2019) (34)
- Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study. (2012) (33)
- Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency. (2003) (33)
- 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report (2019) (33)
- A 24‐Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients (2020) (32)
- Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS. (2007) (32)
- Gender, low Kt/V, and mortality in Japanese hemodialysis patients: Opportunities for improvement through modifiable practices (2014) (32)
- International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study. (2016) (32)
- Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double-blind, placebo-controlled, short-term trial. (2005) (31)
- Increased risk of malignancy and blood-membrane interactions in uraemic patients. (1994) (31)
- Is aplastic osteodystrophy a disease of malnutrition? (2000) (30)
- Low Hemoglobin Levels and Hypo‐Responsiveness to Erythropoiesis‐Stimulating Agent Associated With Poor Survival in Incident Japanese Hemodialysis Patients (2014) (30)
- Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan Dialysis Outcomes and Practice Patterns Study (2009) (30)
- 2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients (2012) (30)
- Prescription of potentially inappropriate medications to elderly hemodialysis patients: prevalence and predictors. (2015) (29)
- Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open‐label, multicentre, 12‐week phase III study (2017) (29)
- Revisiting Interdialytic Weight Gain and Mortality Association With Serum Albumin Interactions: The Japanese Dialysis Outcomes and Practice Pattern Study. (2017) (29)
- Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis. (2013) (28)
- rHuEPO enhances the production of plasminogen activator inhibitor-1 in cultured endothelial cells. (1996) (28)
- Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome. (1999) (27)
- Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation (2016) (26)
- Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients. (2010) (26)
- Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial (2021) (26)
- Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns. (2011) (26)
- Ultrapure Dialysate Influences Serum Myeloperoxidase Levels and Lipid Metabolism (2009) (26)
- Effects of anemia correction by erythropoiesis-stimulating agents on cardiovascular function in non-dialysis patients with chronic kidney disease. (2012) (26)
- Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study (2016) (25)
- Randomized Controlled Trial of Bixalomer Versus Sevelamer Hydrochloride in Hemodialysis Patients With Hyperphosphatemia (2014) (25)
- Dose‐response Study of 22‐Oxacalcitriol in Patients with Secondary Hyperparathyroidism (2004) (25)
- The Effect of Continuous Veno‐Venous Hemofiltration or Direct Hemoperfusion With Polymyxin B‐Immobilized Fiber on Neutrophil Respiratory Oxidative Burst in Patients With Sepsis and Septic Shock (2006) (25)
- Dose Determination of Cinacalcet Hydrochloride in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism (2008) (25)
- Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial. (2021) (24)
- Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS (2014) (24)
- Proposal for the Shared Decision‐Making Process Regarding Initiation and Continuation of Maintenance Hemodialysis (2015) (24)
- Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients (2010) (24)
- Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure. (1996) (24)
- A case of acute spontaneous epidural haematoma in a chronic renal failure patient undergoing haemodialysis: successful outcome with surgical management. (1999) (24)
- Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD (2021) (24)
- Immune and inflammatory mechanisms (2011) (23)
- Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. (2013) (23)
- Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease (2019) (23)
- Association of coping strategies with mortality and health-related quality of life in hemodialysis patients: The Japan Dialysis Outcomes and Practice Patterns Study (2017) (23)
- Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan. (1990) (23)
- Biocompatibility and Permeability of Dialyzer Membranes Do Not Affect Anemia, Erythropoietin Dosage or Mortality in Japanese Patients on Chronic Non-Reuse Hemodialysis: A Prospective Cohort Study from the J-DOPPS II Study (2008) (23)
- Molidustat for the treatment of renal anaemia in patients with non-dialysis-dependent chronic kidney disease: design and rationale of two phase III studies (2019) (22)
- Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism (2018) (22)
- Mineral and Bone Disorders Outcomes Study for Japanese Chronic Kidney Disease Stage 5D Patients: Rationale and Study Design (2011) (22)
- Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study (2018) (22)
- Impact of Cinacalcet Hydrochloride on Bone Histology in Patients with Secondary Hyperparathyroidism (2008) (22)
- Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan (2016) (22)
- RETRACTED ARTICLE: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease (2013) (22)
- β-Blocker Prescription and Outcomes in Hemodialysis Patients from The Japan Dialysis Outcomes and Practice Patterns Study (2009) (22)
- Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients. (2003) (21)
- Involvement of Matrix Metalloproteinase‐2 in the Development of Medial Layer Vascular Calcification in Uremic Rats (2011) (21)
- Diagnostic significance of serum soluble transferrin receptors in various anemic diseases: the first multi-institutional joint study in Japan. (2002) (21)
- Effect of anemia correction to the modestly high hemoglobin level in patients with chronic kidney disease on left ventricular hypertrophy (2013) (21)
- Disappearance of Association in Diabetic Patients on Hemodialysis between Anemia and Mortality Risk: The Japan Dialysis Outcomes and Practice Pattern Study (2012) (21)
- Minor Elevation in C-Reactive Protein Levels Predicts Incidence of Erythropoiesis-Stimulating Agent Hyporesponsiveness among Hemodialysis Patients (2015) (21)
- Depressive symptoms predict the subsequent risk of bodily pain in dialysis patients: Japan Dialysis Outcomes and Practice Patterns Study. (2009) (21)
- Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study (2015) (20)
- Association of blood pressure with all‐cause mortality and stroke in Japanese hemodialysis patients: The Japan dialysis outcomes and practice pattern study (2014) (20)
- IL-17A stimulates granulocyte colony-stimulating factor production via ERK1/2 but not p38 or JNK in human renal proximal tubular epithelial cells. (2012) (20)
- Cost‐Effectiveness of Maintenance Hemodialysis in Japan (2015) (20)
- Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis. (2019) (19)
- Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies (2019) (19)
- Comparative clinical trial of regional anticoagulation for hemodialysis. (1988) (19)
- Darbepoetin Alfa Effectively Maintains Hemoglobin Concentrations at Extended Dose Intervals Relative to Intravenous rHuEPO in Japanese Dialysis Patients (2007) (19)
- Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease. (2010) (18)
- Clinical Effect of Short Daily In-Center Hemodialysis (2003) (18)
- [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease]. (2004) (18)
- [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD]. (2004) (18)
- Development of a regenerated cellulose non-complement activating membrane for hemodialysis. (1986) (18)
- CKD-MBD: impact on management of kidney disease (2007) (18)
- Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan (2010) (17)
- Clinical Effects of L-Threo-3,4-Dihydroxyphenylserine on Orthostatic Hypotension in Hemodialysis Patients (2002) (17)
- Effects of L-Threo-3,4-Dihydroxyphenylserine on Orthostatic Hypotension in Hemodialysis Patients (2002) (17)
- Therapeutic Effects of Human Mesenchymal Stem Cells in Wistar-Kyoto Rats with Anti-Glomerular Basement Membrane Glomerulonephritis (2013) (17)
- Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study (Co‐JET study) (2014) (17)
- Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease . (2013) (17)
- Clinical Effect of Intravenous Calcitriol Administration on Secondary Hyperparathyroidism (2002) (17)
- Dietary Patterns and Clinical Outcomes in Hemodialysis Patients in Japan: A Cohort Study (2015) (16)
- Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study (J-DOPPS). (2019) (16)
- Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study (2021) (16)
- Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan (2013) (16)
- Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. (1991) (16)
- Management of secondary hyperparathyroidism of dialysis patients (2003) (16)
- Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis. (2003) (16)
- Clinical Expectation of Online Hemodiafiltration: A Japanese Perspective (2015) (16)
- Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis (2019) (15)
- Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF. (2003) (15)
- Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients. (2017) (15)
- Intravenous Phosphate Loading Increases Fibroblast Growth Factor 23 in Uremic Rats (2014) (15)
- A case of lupus nephritis coexisting with podocytic infolding associated with Takayasu’s arteritis (2008) (15)
- Clinical Analysis of Renoprotective Responding Patients Administrated with Oral Adsorbent in Chronic Renal Failure Secondary to Chronic Glomerulonephritis (2003) (15)
- Plasma exchange for acquired hemophilia: a case report. (1999) (15)
- High Hemoglobin Levels Maintained by an Erythropoiesis‐Stimulating Agent Improve Renal Survival in Patients with Severe Renal Impairment (2015) (15)
- Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats. (2008) (15)
- Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan. (1988) (15)
- 2011 JSDT Standard on the Management of Endotoxin Retentive Filter for Dialysis and Related Therapies (2013) (15)
- Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial (2014) (14)
- Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study (2018) (14)
- Time-Dependent Resistance to Erythropoiesis-Stimulating Agent and Mortality in Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study (2013) (14)
- Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia (2008) (14)
- Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study (2018) (14)
- Up-regulation of Cbfa 1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism (2006) (14)
- Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease. (2002) (14)
- The Blood Compatibilities of Blood Purification Membranes and Other Materials Developed in Japan (2011) (14)
- The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study (2017) (14)
- Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism (2019) (14)
- Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study (2021) (14)
- Multicenter Study of Pegylated Interferon α‐2a Monotherapy for Hepatitis C Virus‐Infected Patients on Hemodialysis: REACH Study (2014) (14)
- Diary of a Japanese nephrologist during the present disaster. (2011) (14)
- The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure. (1995) (14)
- Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patients. (1995) (14)
- Inflammation and Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients: A Self-matched Longitudinal Study of Anemia Management in the Dialysis Outcomes and Practice Patterns Study (DOPPS) (2020) (14)
- Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis (2021) (14)
- Biocompatible characteristics of high-performance membranes. (2011) (14)
- Quality of Life Improvements in Dialysis Patients Receiving Darbepoetin Alfa (2008) (14)
- Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients (2018) (13)
- A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study (2021) (13)
- Impact of Serum Apolipoprotein A‐IV as a Marker of Cardiovascular Disease in Maintenance Hemodialysis Patients (2010) (13)
- A study of oral adsorbent in chronic renal failure. (1991) (13)
- Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23: Post Hoc Analysis of an Open-label Study. (2018) (13)
- A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study (2021) (13)
- Association of Serum Bicarbonate with Bone Fractures in Hemodialysis Patients: The Mineral and Bone Disorder Outcomes Study for Japanese CKD Stage 5D Patients (MBD-5D) (2014) (13)
- Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study (2018) (13)
- A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients . (2017) (12)
- Japanese Society for Dialysis Therapy: New President's Address (2008) (12)
- Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan (2018) (12)
- A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis. (1999) (12)
- Olmesartan Medoxomil Is Associated with Decreased Plasma AGEs, Pentosidine, and N-(Epsilon)-Carboxymethyl-Lysine Levels in Hemodialysis Patients (2012) (12)
- Design and baseline characteristics of the LANDMARK study (2016) (12)
- A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study (2016) (12)
- Membranous nephropathy that first presented in pregnancy. (2013) (12)
- Darbepoetin Alfa (KRN321) Administered Intravenously Once Monthly Maintains Hemoglobin Levels in Peritoneal Dialysis Patients (2008) (12)
- Plasma exchange for thrombocytopenia in antiphospholipid syndrome: a case report. (1998) (12)
- Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells. (2006) (12)
- A new method for removal of albumin-binding uremic toxins: efficacy of an albumin-dialysate. (2001) (12)
- Comparison of Paricalcitol With Maxacalcitol Injection in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism (2015) (12)
- Renal protective effects of pitavastatin on spontaneously hypercholesterolaemic Imai Rats. (2007) (12)
- Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration. (2007) (11)
- New strategies for the treatment of secondary hyperparathyroidism. (2003) (11)
- Efficacy and Safety of Molidustat for Anemia in ESA-Naive Nondialysis Patients: A Randomized, Phase 3 Trial (2021) (11)
- Effect of renal impairment on the pharmacokinetics of memantine. (2012) (11)
- Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients (2019) (11)
- Long‐Term Treatment of Hyperphosphatemia With Bixalomer in Japanese Hemodialysis Patients (2013) (11)
- MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits (2009) (11)
- Involvement of the Basilar Artery in Diabetes Mellitus: An MRI Study of Brainstem Infarctions (2010) (11)
- Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities (2012) (11)
- Intracranial dilative arteriopathy is associated with chronic kidney disease and small vessel diseases in the elderly. (2009) (11)
- A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levels. (2010) (11)
- A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism (2017) (11)
- Effect of dialysis membranes and ACE inhibitor on bradykinin levels during hemodialysis. (1994) (10)
- Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism. (2006) (10)
- Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis. (1991) (10)
- Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy. (2001) (10)
- SP309SAFETY AND EFFICACY OF MOLIDUSTAT IN ERYTHROPOIESIS STIMULATING AGENTS (ESA) PRE-TREATED ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND) (2016) (10)
- Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol. (2009) (10)
- Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study. (2017) (10)
- SO036MOLIDUSTAT INCREASES HAEMOGLOBIN IN ERYTHROPOIESIS STIMULATING AGENTS (ESA)-NAIVE ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND) (2016) (10)
- Removal of beta-2-microglobulin by direct hemoperfusion with a newly developed adsorbent. (1987) (9)
- Plasma beta-thromboglobulin levels in chronic renal failure patients. (1981) (9)
- Classification of dialysis membranes by performance. (1995) (9)
- Relative hypoparathyroidism in hemodialysis patients. (1995) (9)
- Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan (2018) (9)
- Development of a new cellulose triacetate membrane with a microgradient porous structure for hemodialysis. (1998) (9)
- Pharmacokinetics of darbepoetin alfa after single, intravenous or subcutaneous administration in Japanese pediatric patients with chronic kidney disease (2014) (9)
- Modulation of parathyroid cell function by calcium ion in health and uremia. (1999) (9)
- Nafamostat as Anticoagulant for Membrane Plasmapheresis in high Bleeding risk Patients (1992) (9)
- Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients (2020) (9)
- Role of uremic and endothelial factors in the development of beta 2-microglobulin amyloidosis. (1993) (9)
- Survey of dialysis therapy during the Great East Japan Earthquake Disaster and recommendations for dialysis therapy preparation in case of future disasters (2016) (9)
- Effects of Calcimimetic Combined with an Angiotensin-Converting Enzyme Inhibitor on Uremic Cardiomyopathy Progression (2011) (9)
- Anemia in conventional hemodialysis: Finding the optimal treatment balance (2018) (9)
- Impact of nutritional index on the association between phosphorus concentrations and mortality in haemodialysis patients: a cohort study from dialysis outcomes and practice pattern study in Japan (2017) (9)
- New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients (2008) (8)
- Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy (2016) (8)
- Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (2017) (8)
- Calcium abnormalities of dialysis patients (2005) (8)
- Assessment of CYP‐Mediated Drug Interactions for Evocalcet, a New Calcimimetic Agent, Based on In Vitro Investigations and a Cocktail Study in Humans (2018) (8)
- Type I Angiotensin II Receptor Blockade Reduces Uremia‐Induced Deterioration of Bone Material Properties (2020) (8)
- Diagnosing Alport syndrome using electron microscopy of the skin. (2008) (8)
- The role of calcium-sensing receptor abnormality in the pathogenesis of secondary hyperparathyroidism. (1999) (8)
- Development and validation of a prediction model for loss of physical function in elderly hemodialysis patients (2017) (8)
- Clinical effects of a polyethylene glycol grafted cellulose membrane on thrombogenicity and biocompatibility during hemodialysis. (1990) (7)
- Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan (2011) (7)
- [Validation of the Japanese SF-36 v2 acute form in patients with chronic kidney disease]. (2008) (7)
- Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats (2014) (7)
- Estimation of beta-2-microglobulin production from lymphocytes in hemodialysis patients. (1989) (7)
- Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients (2021) (7)
- Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD) (2005) (7)
- Extracorporeal Albumin Dialysis (2004) (7)
- Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial (2016) (7)
- Symptomatic Bradycardia Probably Due to Tizanidine Hydrochloride in a Chronic Hemodialysis Patient (2005) (7)
- [Management of chronic kidney disease--preventing the progression of renal disease]. (2008) (7)
- Elimination of beta 2-microglobulin by a new polyacrylonitrile membrane dialyser: mechanism and physiokinetics. (1989) (7)
- Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients (2021) (7)
- Research on kidney and mineral metabolism in Japan: past, present, and future (2017) (7)
- FP380JTZ-951, AN ORAL NOVEL HIF-PHD INHIBITOR, ELEVATES HEMOGLOBIN IN JAPANESE ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (2015) (7)
- Molidustat for anemia correction in Japanese patients undergoing hemodialysis: a single‐arm, phase 3 study (2021) (7)
- Impact of Early Referral to Nephrologist on Mental Health among Hemodialysis Patients: A Dialysis Outcomes and Practice Patterns Study (DOPPS) (2009) (7)
- Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial) (2016) (7)
- Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial. (2020) (7)
- SP388UNIQUE HEMOGLOBIN A1C LEVEL DISTRIBUTION AND ITS RELATIONSHIP WITH MORTALITY SEEN FOR DIABETIC JAPANESE HEMODIALYSIS PATIENTS: RESULTS FROM THE JAPANESE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (2016) (7)
- Dose‐Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double‐Blind, Randomized, Placebo‐Controlled and Sevelamer Hydrochloride‐Controlled Open‐Label, Parallel Group Study (2014) (7)
- Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study (2014) (7)
- Two long‐term phase 3 studies of enarodustat (JTZ‐951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND‐Long and HD‐Long studies (2021) (7)
- Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients (2017) (6)
- Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report. (2001) (6)
- Results of the international DOPPS hemodialysis study in Japan (2004) (6)
- Assessment of Inflow of Endotoxin and Its Fragments in Patients on Maintenance Hemodialysis (2011) (6)
- Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events (2020) (6)
- A fulminant case of renal vein thrombosis in a patient with autoimmune disorder and membranous nephropathy. (2008) (6)
- Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co‐JET Study (2016) (6)
- Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells. (2007) (6)
- Population pharmacokinetics of darbepoetin alfa in peritoneal dialysis and non-dialysis patients with chronic kidney disease after single subcutaneous administration (2009) (6)
- Direct Injection of Calcitriol or Its Analog Improves Abnormal Gene Expression in the Hyperplastic Parathyroid Gland in Uremia (2007) (6)
- Effects of 1,25-dihydroxy-22-oxavitamin D3 on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism (2002) (6)
- Prognostic Factors for a Composite End‐Point of Renal Outcomes in Patients With Chronic Kidney Disease (2006) (5)
- Parathyroid Hormone Control Survey to Determine Inter‐method and Inter‐lab Variations in Japan (2011) (5)
- [Kidney as a regulating organ for calcium and phosphate homeostasis]. (2007) (5)
- Clinical significance of parathyroid intervention on CKD-MBD management (2008) (5)
- Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan (2013) (5)
- Analysis of 2897 hospitalization events for patients with chronic kidney disease: results from CKD-JAC study (2019) (5)
- Effectiveness of SARS‐CoV‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study (2022) (5)
- Baseline characteristics and anemia treatment for new hemodialysis patients (2008) (5)
- Correction to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study (2018) (5)
- Proliferating Potential and Apoptosis in the Development of Secondary Hyperparathyroidism: A Study Based on Ki‐67 Immunohistochemical Staining and the Terminal dUTP Nick‐End Labeling Assay (2008) (5)
- Increased Mortality Rate after Hospitalization Among Chronic Hemodialysis Patients: A Prospective Cohort Study (2018) (4)
- [Carpal tunnel syndrome in hemodialysis patients]. (2000) (4)
- IL-17 A stimulates granulocyte colony-stimulating factor production via ERK 1 / 2 but not p 38 or JNK in human renal proximal tubular epithelial cells (2011) (4)
- Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study (2022) (4)
- IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF- and IL-1 (2010) (4)
- FO019JTZ-951, AN ORAL NOVEL HIF-PHD INHIBITOR, ELEVATES HEMOGLOBIN IN JAPANESE ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING MAINTENANCE HEMODIALYSIS (2015) (4)
- [Role of the kidney in mineral metabolism]. (2007) (4)
- Asymptomatic large T2 high-signal pontine lesions that are different from ischemic rarefaction. (2008) (4)
- Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan (2020) (4)
- Various Dietary Protein Intakes and Progression of Renal Failure in Spontaneously Hypercholesterolemic Imai Rats (2007) (4)
- Active vitamin D analogs, maxacalcitol and alfacalcidol, as maintenance therapy for mild secondary hyperparathyroidism in hemodialysis patients - a randomized study. (2014) (4)
- Erratum: Factors associated with health-related quality of life among hemodialysis patients in the DOPPS (Quality of Life Research (2007) 16, (545-557) DOI: 10.1007/s11136-006-9143-7) (2007) (4)
- Olmesartan Medoxomil Treatment Is Associated with Decreased Plasma B-Type Natriuretic Peptide Levels in Patients on Hemodialysis (2012) (4)
- Granulomatous interstitial nephritis in a renal allograft (2012) (4)
- Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS) (2019) (4)
- Pharmacokinetic and Pharmacodynamic Properties of Intravenous Darbepoetin Alfa (KRN321) in Japanese Hemodialysis Patients (2007) (4)
- The Influence of Formula Concentration on the Absorption of Darbepoetin Alfa after Subcutaneous Administration (2010) (4)
- Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism (2020) (4)
- Clinical evaluation of FUT-175 as a regional anti-coagulant in hemodialysis (1987) (4)
- Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study (2020) (4)
- Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients (2017) (4)
- A case of thrombotic thrombocytopenic purpura refractory to plasma exchange. (2001) (4)
- Evaluation of short-acting anticoagulants for hemodialysis (1988) (3)
- Molidustat for the treatment of anemia in Japanese patients undergoing peritoneal dialysis: a single‐arm, open‐label, phase 3 study (2021) (3)
- Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat (2022) (3)
- Body Mass Index Change and Hospitalization Risk in Elderly Hemodialysis Patients: Results from Japanese Dialysis Outcomes and Practice Patterns Study (2018) (3)
- [Long-term clinical effect of maxacalcitol on hemodialysis patients with secondary hyperparathyroidism]. (2002) (3)
- Cardiovascular and Stroke Risk in Japanese Hemodialysis Patients With Atrial Fibrillation (2016) (3)
- Results of the survey on practice patterns including MBD management at dialysis facilities (2011) (3)
- SP334IRON REGULATION BY MOLIDUSTAT, BAY 85-3934, A DAILY ORAL HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2018) (3)
- A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan (2022) (3)
- Malnutrition and cerebral white matter lesions in dialysis patients (2008) (3)
- Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism (2019) (3)
- Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study (2019) (3)
- Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis (2020) (3)
- Development of a Technique for Introduction of an Expressed cDNA into Parathyroid Cells by Direct Injection (2010) (3)
- How to Apply and Adapt International Guidelines on Bone Metabolism and Disease to the Management of Japanese Dialysis Patients (2005) (3)
- Long‐Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis (2017) (3)
- [Effect of an oral sorbent (AST-120) on the clinical course of uremic peak 2a in chronic renal failure]. (1987) (3)
- [Vitamin D metabolism and chronic kidney disease]. (2006) (3)
- Clinical Study of Cinacalcet in Japan (2008) (3)
- [Case of microscopic polyangiitis presenting initially as prostatic vasculitis]. (2009) (3)
- DIALYSIS VASCULAR ACCESS (2014) (3)
- Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study (2022) (3)
- [Anticoagulant effect of a single bolus injection of parnaparin sodium (LHG) on a hemodialysis model in dogs]. (1994) (3)
- [Overview of dialysis therapy for diabetic nephropathies]. (2005) (3)
- Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events (2021) (3)
- Evaluation of changes in ferritin levels during sucroferric oxyhydroxide treatment (2018) (2)
- Erratum: Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: The Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS) (Hemodiaysis International (2007) vol. 11 (3) (340-348)) (2009) (2)
- DIALYSIS BONE DISEASE (2014) (2)
- Burden of Illness Associated With Anaemia In Chronic Kidney Disease In Japan: A Literature Review (2017) (2)
- [Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics]. (2005) (2)
- Uremic Toxities and Dialytic removal of Phosphate. (1992) (2)
- Influence of Staff Encouragement on Perceived Burden of Dietary Restriction Among Patients Living Alone (2016) (2)
- Dialysis‐related practice patterns among hemodialysis patients with cancer (2018) (2)
- Associations among Darbepoetin-α, CD34+ Cells and Cardiovascular Disease Events in Patients on Hemodialysis (2012) (2)
- Thrombotic Thrombocytopenic Purpura‐like Thrombocytopenia Closely Related to Uremia: Report of Two Cases (2007) (2)
- SaO036Efficacy and safety of daprodustat compared with darbepoetin alfa in Japanese hemodialysis patients with anemia: a randomized, double-blind, phase 3 trial (2019) (2)
- Treatment of anemia associated with chronic kidney disease with the HIF prolyl hydroxylase inhibitor enarodustat: A review of the evidence (2022) (2)
- Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients (2021) (2)
- Adsorbent: a determinant for the future development of therapeutic apheresis. (1998) (2)
- Therapeutic Apheresis and Dialysis: 20th Year of Publication (2016) (2)
- POS-244 A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE COMPARATOR CONVERSION STUDY OF ROXADUSTAT IN NON–DIALYSIS-DEPENDENT (NDD) PATIENTS WITH ANEMIA IN CHRONIC KIDNEY DISEASE (CKD) (2021) (2)
- Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus Darbepoetin (2022) (2)
- Low serum concentration of selenium in hemodialysis patients (2004) (2)
- Pharmacokinetic Study of Rilmazafone Hydrochloride in Patients with Chronic Renal Failure (1992) (2)
- Development of a technique for introduction of an expressed complementary deoxyribonucleic acid into parathyroid cells by direct injection. (2010) (2)
- Therapy prior to hemodialysis (1982) (2)
- [Low PTH level and adynamic bone disease in dialysis patients]. (2004) (2)
- Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial (2021) (2)
- MP361EFFICACY AND SAFETY OF A NOVEL INTRAVENOUS CALCIMIMETIC, ONO-5163 (ETELCALCETIDE) IN JAPANESE HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM : RESULTS OF A PLACEBO CONTROLLED PHASE III STUDY (2016) (2)
- Blood Pressure Levels and Mortality Risk among Hemodialysis Patients: Results from the Dialysis Outcomes and Practice Patterns Study (2014) (2)
- Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis (2017) (2)
- Current Status of Therapeutic Apheresis in Japan: Is it a Better Example for Worldwide Clinical Apheresis? (1998) (2)
- Intradialytic Ultrafiltration Volume and Vascular Access Outcomes: A Japan Dialysis Outcomes and Practice Patterns Study Subanalysis (2016) (2)
- Membranous glomerulonephropathy in a patient with bullous pemphigoid (2017) (2)
- [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients]. (1990) (2)
- [Dialysis encephalopathy, dialysis dementia]. (2000) (2)
- [Detection of uremic peaks by high performance liquid chromatography and their behavior]. (1986) (2)
- [The effect of ferric citrate hydrate as an iron replacement therapy in Japanese patients with iron deficiency anemia]. (2021) (1)
- MP368A NOVEL INTRAVENOUS CALCIMIMETIC, ONO-5163 (ETELCALCETIDE): A MULTICENTER, SINGLE AND MULTIPLE DOSE STUDY IN JAPANESE HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM (2016) (1)
- Erratum to: The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study (2017) (1)
- Protein-energy wasting, inflammation and oxidative stress (2009) (1)
- Evaluation of short-acting anticoagulants for hemodialysis-Optimum method of estimating anticoagulation- (2009) (1)
- Population-level associations of achievement of targets for bone-mineral markers with survival in haemodialysis patients with mildly elevated intact-PTH levels: a case-cohort study (2019) (1)
- The difference between rHuEPO and long-acting ESA for hemoglobin variability in hemodialysis patients (2011) (1)
- Authors' Reply. (2021) (1)
- Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia (2021) (1)
- Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention (2008) (1)
- Biocompatibility.Physiological significance of its disease state. (1991) (1)
- What are the Newer Applications for Therapeutic Apheresis in Nephrology? (2016) (1)
- Primary and secondary glomerulonephritis I (2012) (1)
- Elderly onset systemic lupus erythematosus (SLE) presenting with disseminated intravascular coagulation (DIC) (2008) (1)
- P1868TO INVESTIGATE THE EFFICACY AND SAFETY OF MOLIDUSTAT IN NON-DIALYSIS PATIENTS WITH RENAL ANEMIA WHO ARE TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS: MIYABI ND-M (2020) (1)
- [Role of kidney in calcium homeostasis and premature aging]. (2008) (1)
- Length of hospital stay is associated with a decline in activities of daily living in hemodialysis patients: a prospective cohort study (2019) (1)
- First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants (2022) (1)
- Development of ion-exchange membrane for an artificial kidney system. (1981) (1)
- [The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure]. (1991) (1)
- Diary of a Japanese nephrologist during the present disaster: part II. (2011) (1)
- Parathyroid function in end-stage penal failure (1993) (1)
- Serum Paraoxonase 1 (PON1) Concentration as a Marker of Left Ventricular Mass Index (LVMI) and Atherosclerosis in Hemodialysis Patients (2010) (1)
- Changes in endocrinological functions in hemodialysis patients associated with improvements in anemia after recombinant human erythropoietin therapy. (1990) (1)
- Myocardial SPECT Images in Incident Hemodialysis Patients Without Ischemic Heart Disease (2015) (1)
- Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan (2022) (1)
- Very high incidence and relatively mild clinical symptoms of dialysis population with hypoparathyroidism (1996) (1)
- Estimating the causal effect of transient anemia status on renal and cardiovascular outcomes in community-dwelling patients in Japan at the beginning of impaired renal function using marginal structural modeling (2021) (1)
- Evaluation of beta 2-microglobulin removal with high-performance hemodiafiltration. (1988) (1)
- P1866TO INVESTIGATE THE EFFICACY AND SAFETY OF MOLIDUSTAT IN NON-DIALYSIS PATIENTS WITH RENAL ANEMIA WHO ARE NOT TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS: MIYABI ND-C (2020) (1)
- Bone Disease in Chronic Renal Failure (2002) (1)
- Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism. (2002) (1)
- Plasma bradykinin levels during hemodialysis with PAN DX and polysulfone membranes with and without concurrent ACE inhibitor. (1995) (1)
- P1404A PHASE 2 OPEN-LABEL, SINGLE-ARM, FIRST JAPANESE STUDY OF TENAPANOR, A NOVEL PHOSPHATE ABSORPTION INHIBITOR, FOCUSING ON PILL BURDEN DECREASE IN PATIENTS WITH HYPERPHOSPHATEMIA UNDERGOING HEMODIALYSIS (2020) (1)
- Correction to: Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis (2018) (1)
- MODIFICATION OF POROUS CELLULOSE DIALYSIS MEMBRANE BY POLYETHYLENE GLYCOL (PEG) GRAFTING (1997) (1)
- The benefit of hydroxyapatite(HA) for the biocompatibility and adhesion to the soft tissues. (1988) (1)
- RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan (2017) (1)
- MO002OPHTHALMOLOGICAL EFFECTS OF ROXADUSTAT IN THE TREATMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE PATIENTS ON DIALYSIS IN A PHASE 3, RANDOMISED, DOUBLE-BLIND, ACTIVE-COMPARATOR CONVERSION STUDY (2020) (1)
- [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder]. (2010) (1)
- Intra-Dialytic Hemoglobin Changes and Cardiovascular Events: A Cohort Study on Dialysis Outcomes and Practice Patterns in Japan (2019) (1)
- Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study” (2019) (1)
- Pharmacokinetic/pharmacodynamic modeling of roxadustat's effect on LDL cholesterol in patients in Japan with dialysis-dependent chronic kidney disease and anemia. (2022) (1)
- Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial (2020) (1)
- Dialysis membranes in the year 2000: performance and biocompatibility. (1996) (1)
- Cellular changes following direct vitamin D injection into the uraemia-induced hyperplastic parathyroid gland (2008) (1)
- CKD GENERAL AND CLINICAL EPIDEMIOLOGY 1 (2014) (1)
- [Clinical guideline review: Standards for initiation of chronic dialysis]. (2002) (1)
- The DOPPS estimate of patient life years attributable to modifiable hemodialysis-Practices in Japan- (2008) (1)
- [Drug-induced nephrotic syndrome]. (2012) (1)
- Penis necrosis in a diabetic dialysis patient. A case report (2002) (1)
- A case of calciphylaxis effectively treated using cinacalcet (2013) (1)
- [Uremic peak 2a in high performance liquid chromatography--acidic components and their membrane permeability]. (1986) (1)
- PREVALENT HAEMODIALYSIS PATIENTS (2013) (1)
- Associations among epoetin therapy, inflammation, nutritional status, and mortality in patients on hemodialysis. (2014) (1)
- Serum TNF-.ALPHA. concentration in hemodialysis patients: Effects of dialysis procedure.:EFFECTS OF DIALYSIS PROCEDURE (1991) (0)
- DOPPS Investigators recognized with the Belding H. Scribner Award (2004) (0)
- Cinacalcet : benefit and cost. Authors' reply (2008) (0)
- Heart and bone in CKD - B (2013) (0)
- Substitution and Replacement Fluid in Field of Blood Purification Therapy (1999) (0)
- Welcome Letter from the Congress President (2006) (0)
- CHANGES IN ADHESION MOLECULES ON LEUKOCYTE AND PLATELET DURING PLASMAPHERESIS (PP) (1996) (0)
- Results of a survey on practice patterns at the end of a study involving CKD-MBD management at dialysis facilities: : As a part of MBD-5D study@@@―透析MBDアウトカム研究より― (2013) (0)
- First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties (2022) (0)
- Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan (2019) (0)
- Dialysis physicians’ referral behaviors for hemodialysis patients suspected of having cancer: A vignette-based questionnaire study (2018) (0)
- [Thiazide-induced hypercalcemia (author's transl)]. (1978) (0)
- [Pulse therapy of nephrotic syndrome]. (1978) (0)
- Contents Vol. 105, 2007 (2007) (0)
- Evaluation of ß2-Microglobulin Removal with High-Performance Hemodiafiltration (2008) (0)
- [New preparations of erythropoietin]. (2004) (0)
- The efficiency and safety of short daily hemodialysis using a daily hemodialysis system (AEK-10). (2003) (0)
- Subject Index Vol. 90, 2002 (2002) (0)
- Subject Index Vol. 90, 2002 (2002) (0)
- Body Mass Index Modified Predictive Ability Of Biomarkers For Protein-Energy Wasting In Prevalent Hemodialysis Patients (2012) (0)
- Experimental pathology - 1 (2009) (0)
- Congress President's Report: 6th World Congress of the International Society for Apheresis (2007) (0)
- Acknowledgment of Reviewers (2020) (0)
- A case of recurrent vascular access failure in a patient with relapsing polychondritis receiving maintenance hemodialysis (2006) (0)
- Correction to: Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients (2019) (0)
- [Recent progress in hemodialysis]. (1995) (0)
- [Complications suffered by dialysis patients. 4. Hematologic problems]. (2000) (0)
- A case of acute renal failure due to mizoribine-associated uric acid nephropathy (2007) (0)
- Nephrology Dialysis Transplantation Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients : results of a preliminary study (2005) (0)
- [Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds]. (1987) (0)
- Status of DOPPS in 12 Countries Research on Vascular Access Abstracts and Presentations Worldwide Questions and Answers (2002) (0)
- Therapy of the renal anemia of chronic renal failure (1982) (0)
- Contents Vol. 105, 2007 (2007) (0)
- Cardiovascular complications - 1 (2009) (0)
- Effect of bixalomer on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a multi-center, randomized controlled trial (2019) (0)
- Upcoming Meetings (2007) (0)
- Bernd Hohenstein appointed as Editor representing the European Group—International Society for Apheresis (2020) (0)
- Therapeutic Apheresis and Therapeutic Plasmapheresis: The Relationship to the Annual Meeting of the Japanese Society for Apheresis (1997) (0)
- Review: Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection (2008) (0)
- Elevated intestinal bacteria-derived putrefactants and intestinal bacterial flora pattern in renal transplantation patients (2003) (0)
- Heparin free hemodialysis using ticlopidine (1980) (0)
- [Chronic kidney disease (CKD) and bone. CKD-MBD managements and view in the future]. (2009) (0)
- Subject Index Vol. 105, 2007 (2007) (0)
- Clinical application of FR-860 to hemodialysis: Multicenter cooperative study in Japan (1991) (0)
- [Dialysis dysequilibrium syndrome(DDS)]. (2000) (0)
- Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells. (1995) (0)
- Efficiency and safety of newly developed therapeutic plasmaseparator composed of polysulfone (1990) (0)
- MP354NO CLEAR ASSOCIATION WAS FOUND BETWEEN HIGH FRACTURE RISK AND MINERAL METABOLIC MARKERS AMONG JAPANESE DIALYSIS PATIENTS (2016) (0)
- Control of severe hyperparathyroidism in dialysis patients with nodular hyperplasia (2008) (0)
- Protein-energy wasting, inflammation and oxidative stress in CKD 5D (2011) (0)
- Bone disease in CKD 5D (2011) (0)
- [Effects of low molecular weight heparin as an anti-coagulant for hemodialysis]. (1990) (0)
- Extracorporeal circulation with the inhibition of thromboxane A2 synthetase. (1986) (0)
- Ischemic heart disease may be associated with poor mental health in hemodialvsis patients (2009) (0)
- PowerPoint Slides for: Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects (2016) (0)
- Beneficial application of hollow fiber with fin to high performance membrane dialyzer. (1987) (0)
- Effective utilization of dialysate by a successive batch dialysis method (1986) (0)
- [Fragility Fractures in Hemodialysis Patients. Uremic bone disease:the effect of medical treatment until now.] (2018) (0)
- [Hyperphosphatemia and hypoparathyroidism]. (2001) (0)
- The Impact Factor (2004) (0)
- [Treatment of nephrogenic anemia]. (2006) (0)
- Preliminary Communication Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in haemodialysis patients: a double-blind, placebo-controlled, short-term trial (2005) (0)
- Cell separating property and clinical effect of lymphocytapheresis with leukocyte removal filter. (1990) (0)
- Erratum to: Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function (2010) (0)
- Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis—A post hoc analysis of the LANDMARK study (2022) (0)
- The characteristic and the clinical evaluation of APS-16 A multi-center study (1995) (0)
- Corrigendum to “Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients,” [Kidney Int. Rep. 2021; https://doi.org/10.1016/j.ekir.2021.08.020] (2021) (0)
- Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism (2022) (0)
- [The new trend on the treatment of secondary hyperparathyroidism]. (2002) (0)
- Progress in Apheresis and Dialysis (2004) (0)
- Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (2018) (0)
- [Studies on protein binding of uremic peak 2a]. (1987) (0)
- Changes in dialysis efficieucy and residual blood during erythropoietin therapy (1989) (0)
- [Chronic kidney diseases and other diseases. 2. Kidney failure]. (2007) (0)
- Retraction Note to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease (2013) (0)
- Guest Editorial (2008) (0)
- [Effect of concomitant therapy on adynamic bone disease]. (2001) (0)
- Upcoming Meetings (2006) (0)
- [108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 3. The interaction between kidney and other organs; What should physicians know about it? (5) Interaction between kidney and bone]. (2011) (0)
- New Reimbursement for Dialysis in Japan (2006) (0)
- Our thanks to ALL healthcare workers on the frontlines caring for our most vulnerable (2020) (0)
- Clinical evaluation of the dialysate of new composition (1982) (0)
- Acknowledgment of Reviewers (2000) (0)
- A case of MPO-ANCA-associated vasculitis due to prosthetic knee infection with Staphylococcus aureus (2009) (0)
- [Electrolyte and mineral metabolism in acute renal failure]. (1983) (0)
- Epoetin and IV iron dose requirements are reduced by hepatitis C infection in hemodialysis patients in the dialysis outcomes and practice patterns study (2009) (0)
- [Choice of maintenance dialysis therapy in patients with CKD stage 5D]. (2009) (0)
- Supplementary Material for: Mineral Metabolism Management in Hemodialysis Patients with Secondary Hyperparathyroidism in Japan: Baseline Data from the MBD-5D (2017) (0)
- [Acid-base imbalance in diabetic mellitus]. (1990) (0)
- Contents Vol. 31, 2011 (2011) (0)
- [Syndrome related to chronic dialysis]. (2000) (0)
- W413 CONTROL OF PHOSPHATEMIA WITH SHORT DAILY HEMODIALYSIS (2003) (0)
- Corrigendum to “Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events” [Kidney Int. Rep. 2020 1670–1678] (2021) (0)
- Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism (2022) (0)
- [Problems in treatment of kidney failure (discussion)]. (1998) (0)
- Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia A Randomized, Double-Blind, Phase 3 Trial (2020) (0)
- Subject Index, Vol. 58, 1991 (1991) (0)
- Mortality of Japanese Dialysis Patients Versus US Counterparts (2012) (0)
- [Current strategy for ESRD in Japan]. (2006) (0)
- Contents Vol. 90, 2002 (2002) (0)
- [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD]. (2011) (0)
- Authors' Reply. (2020) (0)
- [Clinical development of OCT]. (2002) (0)
- Contents Vol. 90, 2002 (2002) (0)
- Therapy prior to hemodialysis-oral adsorbent therapy - (2009) (0)
- Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials. (2023) (0)
- MP339 SUCCESSFUL TREATMENT OF VERY SEVERE OSTEITIS FIBROSA WITH NORMALIZATION OF HYPERPLASTIC PARATHYROID GLAND IN UREMIC RATS (2006) (0)
- Experimental models of CKD (2013) (0)
- Expectation of Online Hemodiafiltration : A Japanese Perspective (2015) (0)
- Bradykinin Production during Blood Purification Therapy : Effects of Material and Anticoagulant : Biocompatibility (1995) (0)
- In Reply to “Letter Regarding ‘Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial’” (2022) (0)
- MO542MOLIDUSTAT FOR ANAEMIA IN JAPANESE PATIENTS UNDERGOING PERITONEAL DIALYSIS: A SINGLE ARM, OPEN-LABEL, PHASE 3 STUDY (2021) (0)
- IMPACT OF VITAMIN K 2 ON VASCULAR CALCIFICATIONS INDUCED BY HIGH DOSES VITAMIN D 3 IN UREMIC RATS (2009) (0)
- Bilateral renal cell carcinoma (RCC) in a patient undergoing hemodialysis for autosomal dominant polycystic kidney disease (ADPKD) manifested by spontaneous cyst rupture and hemorrhage within the cyst. (2001) (0)
- Marked improvement in renal anemia associated with acute hepatitis in a patient under regular hemodialysis (1985) (0)
- Effect of Double-Filtration Plasmapheresis and Glucocorticoid Therapy on Blood Glucose Control in a Patient with Anti-Insulin Antibody-Positive Diabetes Mellitus(Diabetes Mellitus,General Presentation) (1996) (0)
- Hospital infection control in hemodialysis facilities (2000) (0)
- Therapeutic apheresis: further development in the new century. (2001) (0)
- Clinical effect of percutaneous maxacalcitol injection therapy on advanced secondary hyperparathyroidism (2004) (0)
- [Equipments suitable for long-term dialysis: the goals and present status]. (1980) (0)
- 2. Kidney Failure (2007) (0)
- [Enhanced expression of EGFR, TGF-alpha, EGF in hyperplastic parathyroid glands in established stage of renal failure in rats]. (2005) (0)
- Clinical effect of L-threo-3, 4-dihydroxyphenylserine (L-threo-DOPS) on orthostatic hypotension in hemodialysis patients (1997) (0)
- CLINICAL EVALUATION OF A NEW POROUS MEMBRANE DIALYZER COMPOSED OF CELLULOSE-DIACETATE(Altrex^R) (1995) (0)
- Recent Advances in CKD‐MBD Research (2011) (0)
- Erratum to: The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study (2017) (0)
- [Risk management based on results of nationwide questionaire on medical accidents]. (2004) (0)
- Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety". (2021) (0)
- Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study (2022) (0)
- FUNCTIONAL ROLES OF KLOTHO IN THE PROCESS OF RENAL FIBROSIS ASSESSED IN THE CULTURED RENAL EPITHELIAL AND FIBROBLAST CELLS (2013) (0)
- Announcement of Affiliation of JSDT with Therapeutic Apheresisand Dialysis (2003) (0)
- Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial (2022) (0)
- [Calcium sensing receptor (CaR) agonist]. (2005) (0)
- Clinical Nephrology: primary and secondary glomerulonephritis (2011) (0)
- FP647FACILITY BLOOD PRESSURE TARGETS AND RISK OF LOW OBSERVED BLOOD PRESSURE LEVELS IN THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS) (2015) (0)
- Welcome Letter From the Congress President (2006) (0)
- TO022RECONSIDERING INTERDIALYTIC WEIGHT GAIN AND MORTALITY ASSOCIATION WITH SERUM ALBUMIN INTERACTIONS: THE J-DOPPS STUDY (2017) (0)
- [Renal osteodystrophy]. (2004) (0)
- The Authors Reply. (2018) (0)
- [Novel phosphate binders under development]. (2009) (0)
- Comparison of phosphate removal between different dialysis times under constant urea index (1991) (0)
- [significance of PTH (1-84) assay in the management of chronic renal failure and the current status and future of the treatment of renal osteopathy]. (2005) (0)
- JASN3111Letter 2737..2741 (2020) (0)
- ISFA Officers and Board of Trustees (2012) (0)
- [Dialysis-related amyloidosis]. (1992) (0)
- [Hypertension: experimental models]. (2013) (0)
- Japanese Society for Dialysis Therapy: Presidential Address Upon Reappointment (2010) (0)
- Dialytic therapy. I. An advance on dialytic therapy. 1. An advance on the hemodialysis. (1995) (0)
- Target phosphate and calcium levels in patients undergoing hemodialysis: a post-hoc analysis of the LANDMARK study (2022) (0)
- Bone disease - 2 (2009) (0)
- Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan (2020) (0)
- Epidemiology & outcome in CKD 5D (1) (2011) (0)
- Supplementary Material for: Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects (2016) (0)
- [Treatment of uremic patients at high bleeding risk]. (1992) (0)
- Clinical effects of deferoxamine (DFO) on refractory anemia associated with chronic renal failure (1988) (0)
- Effect of oral sorbent (AST-120) on clinical courses of uremic peak 2a in chronic renal failure (2010) (0)
- Clinical effect of new modified cellulose membrane dialyzer on biocompatibility and thrombogenecity during hemodialysis (1991) (0)
- Artificial Liver Support for the Treatment of Fulminant Viral Hepatic Failure : Symposium 4A : Identifications and Effects of Apheresis on Multiple Organ Failure and Fulminant Hepatitis (1995) (0)
- General & clinical epidemiology CKD 1-5 (1) (2011) (0)
- Abdominal X-ray might be a useful tool for assessing medication adherence in patients receiving Lanthanum carbonate (2012) (0)
- [Renal tubular acidosis]. (2000) (0)
- Bone disease - 1 (2009) (0)
- PROSPECTIVE COMPARISON OF CONVENTIONAL TO SHORT DAILY HEMODIALYSIS USING AEK-10(DESIGNED SPECIFICALLY FOR DAILY HEMODIALYSIS) (2003) (0)
- EFFECT OF 25-HYDROXYVITAMIN D 3 ON VASCULAR SMOOTH MUSCLE CELL MINERALIZATION (2013) (0)
- [Basic and clinical aspects of calcimimetics. The pathogesis and treatment of secondary hyperparathyroidism]. (2008) (0)
- POS-292 OPHTHALMOLOGICAL EFFECTS OF ROXADUSTAT IN THE TREATMENT OF ANEMIA IN DIALYSIS-DEPENDENT AND NON–DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: FINDINGS FROM TWO PHASE 3 STUDIES (2021) (0)
- 19th Annual Meeting of the Japanese Society for Kidney Bone Disease. (2008) (0)
- Appreciation for the contribution of the Japanese Society for Dialysis Therapy to development of Therapeutic Apheresis and Dialysis (2021) (0)
- [Renal osteodystrophy and vitamin D]. (2003) (0)
- Clinical evaluation of serum transferrin receptors as an index of iron deficiency in hemodialysis patients (2000) (0)
- I. Transition of the Concept. (2010) (0)
- MP302CLINICAL PREDICTION MODELS FOR PROGRESSION OF CHRONIC KIDNEY DISEASE TO END STAGE KIDNEY FAILURE UNDER PREDIALYSIS NEPHROLOGY CARE: RESULTS FROM THE CHRONIC KIDNEY DISEASE JAPAN COHORT STUDY (2016) (0)
- Does sevelamer have greater skeletal benefit than calcium carbonate in children with secondary hyperparathyroidism? (2006) (0)
- Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Tadao Akizawa?
Tadao Akizawa is affiliated with the following schools:
